Cite

HARVARD Citation

    Ramos, G. et al. (2021). Certolizumab Trough Levels and Antibodies in Crohn Disease: A Single-Center Experience. Crohn's & colitis 360. 3 (3), p. . [Online]. 
  
Back to record